ISEcp1-Mediated Transposition Leads to Fosfomycin and Broad-Spectrum Cephalosporin Resistance in Klebsiella pneumoniae.

Détails

ID Serval
serval:BIB_006C9C8E6CAA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
ISEcp1-Mediated Transposition Leads to Fosfomycin and Broad-Spectrum Cephalosporin Resistance in Klebsiella pneumoniae.
Périodique
Antimicrobial agents and chemotherapy
Auteur⸱e⸱s
Kieffer N., Poirel L., Mueller L., Mancini S., Nordmann P.
ISSN
1098-6596 (Electronic)
ISSN-L
0066-4804
Statut éditorial
Publié
Date de publication
21/04/2020
Peer-reviewed
Oui
Volume
64
Numéro
5
Pages
e00150-20
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
A fosfomycin-resistant and carbapenemase (OXA-48)-producing Klebsiella pneumoniae isolate was recovered, and whole-genome sequencing revealed ISEcp1-bla <sub>CTX-M-14b</sub> tandemly inserted upstream of the chromosomally encoded lysR-fosA locus. Quantitative evaluation of the expression of lysR and fosA genes showed that this insertion brought a strong hybrid promoter leading to overexpression of the fosA gene, resulting in fosfomycin resistance. This work showed the concomitant acquisition of resistance to broad-spectrum cephalosporins and fosfomycin due to a single genetic event.
Mots-clé
Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Cephalosporins/pharmacology, DNA Transposable Elements/genetics, Drug Resistance, Multiple, Bacterial/genetics, Fosfomycin/pharmacology, Genome, Bacterial/genetics, Humans, Klebsiella pneumoniae/drug effects, Klebsiella pneumoniae/genetics, Klebsiella pneumoniae/isolation & purification, Microbial Sensitivity Tests, Mutagenesis, Insertional/genetics, Transcription Factors/genetics, Whole Genome Sequencing, beta-Lactamases/genetics, FOS, FosA, ISEcp1, Klebsiella pneumoniae, fosfomycin
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/03/2020 16:13
Dernière modification de la notice
09/03/2024 8:09
Données d'usage